These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30452907)

  • 21. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
    Kang WL; Xu GS
    Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-199b represses porcine muscle satellite cells proliferation by targeting JAG1.
    Zhu L; Hou L; Ou J; Xu G; Jiang F; Hu C; Wang C
    Gene; 2019 Apr; 691():24-33. PubMed ID: 30599234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.
    Won KY; Kim YW; Kim HS; Lee SK; Jung WW; Park YK
    Hum Pathol; 2013 Aug; 44(8):1648-55. PubMed ID: 23574781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients.
    Joshi D; Chandrakala S; Korgaonkar S; Ghosh K; Vundinti BR
    Gene; 2014 Jun; 542(2):109-12. PubMed ID: 24680705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.
    Jin H; Jang Y; Cheng N; Li Q; Cui PF; Zhou ZW; Jiang HL; Cho MH; Westover KD; Tan QY; Xu CX
    J Exp Clin Cancer Res; 2019 Apr; 38(1):165. PubMed ID: 30987652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity, duplex degradation and subcellular localization of antagomirs.
    Krützfeldt J; Kuwajima S; Braich R; Rajeev KG; Pena J; Tuschl T; Manoharan M; Stoffel M
    Nucleic Acids Res; 2007; 35(9):2885-92. PubMed ID: 17439965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhou SJ; Liu FY; Zhang AH; Liang HF; Wang Y; Ma R; Jiang YH; Sun NF
    Br J Cancer; 2017 Jul; 117(2):233-244. PubMed ID: 28588321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized workflow to modify microRNA expression in primary human intravascular cells.
    Caglayan S; Hansen JB; Snir O
    BMC Immunol; 2023 Feb; 24(1):5. PubMed ID: 36792999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus.
    Jimenez-Mateos EM; Engel T; Merino-Serrais P; Fernaud-Espinosa I; Rodriguez-Alvarez N; Reynolds J; Reschke CR; Conroy RM; McKiernan RC; deFelipe J; Henshall DC
    Brain Struct Funct; 2015 Jul; 220(4):2387-99. PubMed ID: 24874920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge.
    Kent OA; Steenbergen C; Das S
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice.
    Lucas T; Schäfer F; Müller P; Eming SA; Heckel A; Dimmeler S
    Nat Commun; 2017 May; 8():15162. PubMed ID: 28462946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEI-complexed LNA antiseeds as miRNA inhibitors.
    Thomas M; Lange-Grünweller K; Dayyoub E; Bakowsky U; Weirauch U; Aigner A; Hartmann RK; Grünweller A
    RNA Biol; 2012 Aug; 9(8):1088-98. PubMed ID: 22894918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-15a/16-1 Antagomir Ameliorates Ischemic Brain Injury in Experimental Stroke.
    Yang X; Tang X; Sun P; Shi Y; Liu K; Hassan SH; Stetler RA; Chen J; Yin KJ
    Stroke; 2017 Jul; 48(7):1941-1947. PubMed ID: 28546328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles.
    Kwekkeboom RF; Sluijter JP; van Middelaar BJ; Metz CH; Brans MA; Kamp O; Paulus WJ; Musters RJ
    J Control Release; 2016 Jan; 222():18-31. PubMed ID: 26616760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.
    Scherr M; Venturini L; Battmer K; Schaller-Schoenitz M; Schaefer D; Dallmann I; Ganser A; Eder M
    Nucleic Acids Res; 2007; 35(22):e149. PubMed ID: 18025036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
    Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
    Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatiotemporal control of microRNA function using light-activated antagomirs.
    Connelly CM; Uprety R; Hemphill J; Deiters A
    Mol Biosyst; 2012 Nov; 8(11):2987-93. PubMed ID: 22945263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-miRNA Oligonucleotide Therapy for Chondrosarcoma.
    Sun X; Chen Y; Yu H; Machan JT; Alladin A; Ramirez J; Taliano R; Hart J; Chen Q; Terek RM
    Mol Cancer Ther; 2019 Nov; 18(11):2021-2029. PubMed ID: 31341031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.